Digestive remedies have seen prices escalate due to hyperinflation in Argentina. The new government of Milei, which promotes a libertarian economic model, deregulated consumer health prices in January 2024, which had been regulated by the former centre-left government. This measure resulted in a resurgence of inflation driving up prices. Consumer purchasing power has fallen significantly resulting in declining volume sales of most digestive remedies.
The Digestive Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Digestive Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN ARGENTINADISCLAIMERDEFINITIONS
2024 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
Proton pump inhibitors growth to be fuelled by recent switch from RX to OTC
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES